These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The Activities and Secretion of Cytokines Caused by Delamanid on Macrophages Infected by Multidrug-Resistant Lyu XL; Lin TT; Gao JT; Jia HY; Zhu CZ; Li ZH; Dong J; Sun Q; Shu W; Pan LP; Zhang ZD; Li Q Front Immunol; 2021; 12():796677. PubMed ID: 35003120 [TBL] [Abstract][Full Text] [Related]
26. The Medicinal Chemistry of Chalcones as Anti- Rodríguez-Silva CN; Prokopczyk IM; Dos Santos JL Mini Rev Med Chem; 2022; 22(16):2068-2080. PubMed ID: 35156577 [TBL] [Abstract][Full Text] [Related]
27. Identification of Anti-tuberculosis Compounds From Aurone Analogs. Yang D; Taylor ZE; Handy S; Li S; Liu J; Stabenow J; Zalduondo L; Jonsson CB; Altman E; Kong Y Front Microbiol; 2020; 11():1004. PubMed ID: 32508798 [TBL] [Abstract][Full Text] [Related]
28. Indole Derivatives as Anti-Tubercular Agents: An Overview on their Synthesis and Biological Activities. Reddy GS; Pal M Curr Med Chem; 2021; 28(22):4531-4568. PubMed ID: 32951569 [TBL] [Abstract][Full Text] [Related]
29. Synthesis, Structure-Activity Relationship, and Mechanistic Studies of Aminoquinazolinones Displaying Antimycobacterial Activity. Akester JN; Njaria P; Nchinda A; Le Manach C; Myrick A; Singh V; Lawrence N; Njoroge M; Taylor D; Moosa A; Smith AJ; Brooks EJ; Lenaerts AJ; Robertson GT; Ioerger TR; Mueller R; Chibale K ACS Infect Dis; 2020 Jul; 6(7):1951-1964. PubMed ID: 32470286 [TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents. Hwang JM; Oh T; Kaneko T; Upton AM; Franzblau SG; Ma Z; Cho SN; Kim P J Nat Prod; 2013 Mar; 76(3):354-67. PubMed ID: 23360475 [TBL] [Abstract][Full Text] [Related]
31. Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents. Lakshminarayana SB; Huat TB; Ho PC; Manjunatha UH; Dartois V; Dick T; Rao SP J Antimicrob Chemother; 2015 Mar; 70(3):857-67. PubMed ID: 25587994 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy. Hlaka L; Rosslee MJ; Ozturk M; Kumar S; Parihar SP; Brombacher F; Khalaf AI; Carter KC; Scott FJ; Suckling CJ; Guler R J Antimicrob Chemother; 2017 Dec; 72(12):3334-3341. PubMed ID: 28961913 [TBL] [Abstract][Full Text] [Related]
33. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery. de Wet TJ; Warner DF; Mizrahi V Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123 [TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents. Onajole OK; Lun S; Yun YJ; Langue DY; Jaskula-Dybka M; Flores A; Frazier E; Scurry AC; Zavala A; Arreola KR; Pierzchalski B; Ayitou AJ; Bishai WR Chem Biol Drug Des; 2020 Dec; 96(6):1362-1371. PubMed ID: 32515129 [TBL] [Abstract][Full Text] [Related]
36. A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum. Sarathy JP; Xie M; Jones RM; Chang A; Osiecki P; Weiner D; Tsao WS; Dougher M; Blanc L; Fotouhi N; Via LE; Barry CE; De Vlaminck I; Sherman DR; Dartois VA mBio; 2023 Apr; 14(2):e0059823. PubMed ID: 37017524 [TBL] [Abstract][Full Text] [Related]